| Ashley Ford, DO | |
|
200 S Academy Rd, Guthrie, OK 73044-8727 | |
| (405) 260-4246 | |
| (405) 282-8237 |
| Full Name | Ashley Ford |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 14 Years |
| Location | 200 S Academy Rd, Guthrie, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366761173 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 5082 (Oklahoma) | Secondary |
| 207R00000X | Internal Medicine | 5082 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Epworth At Home, Llc | Oklahoma city, OK | Home health agency |
| Epworth At Home, Llc | Oklahoma city, OK | Hospice |
| Good Shepherd Hospice, Inc | Oklahoma city, OK | Hospice |
| Mercy Hospital Oklahoma City, Inc | Oklahoma city, OK | Hospital |
| Epworth Villa Health Services | Oklahoma city, OK | Nursing home |
| The Health Center At Concordia | Oklahoma city, OK | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Long Term Care Specialists, Inc | 3476550740 | 32 |
News Archive
Alcohol will cause around 135,000 cancer deaths over the next 20 years and will cost the NHS an estimated £2 billion in treatments, according to estimates from a new report by Sheffield University, commissioned by Cancer Research UK.
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
Johns Hopkins researchers have developed a novel way to monitor in real time the behavior of the TB bacterium in mouse lungs noninvasively pinpointing the exact location of Mycobacterium tuberculosis. The new monitoring system is expected to speed up what is currently a slow and cumbersome process to test the safety and efficacy of various TB drug regimens and vaccines in animals. Plans are already under way for developing a similar system to monitor TB disease in humans.
This post on the Center for Strategic & International Studies' (CSIS) SmartGlobalHealth.org blog provides resources, including video and publications, related to a December 6 half-day seminar, sponsored by the CSIS Global Health Policy Center, that "focused on the activities, practices, and strategies that characterize the global health outreach of Brazil, China, India, Russia and South Africa, or the BRICS."
Mylan Inc. today announced that it has launched Olanzapine Orally Disintegrating Tablets (ODT), 5 mg, 10 mg, 15 mg and 20 mg, the generic version of Eli Lilly and Company's Zyprexa Zydis Tablets.
› Verified 5 days ago
| Entity Name | Long Term Care Specialists, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497761159 PECOS PAC ID: 3476550740 Enrollment ID: O20061030000218 |
News Archive
Alcohol will cause around 135,000 cancer deaths over the next 20 years and will cost the NHS an estimated £2 billion in treatments, according to estimates from a new report by Sheffield University, commissioned by Cancer Research UK.
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
Johns Hopkins researchers have developed a novel way to monitor in real time the behavior of the TB bacterium in mouse lungs noninvasively pinpointing the exact location of Mycobacterium tuberculosis. The new monitoring system is expected to speed up what is currently a slow and cumbersome process to test the safety and efficacy of various TB drug regimens and vaccines in animals. Plans are already under way for developing a similar system to monitor TB disease in humans.
This post on the Center for Strategic & International Studies' (CSIS) SmartGlobalHealth.org blog provides resources, including video and publications, related to a December 6 half-day seminar, sponsored by the CSIS Global Health Policy Center, that "focused on the activities, practices, and strategies that characterize the global health outreach of Brazil, China, India, Russia and South Africa, or the BRICS."
Mylan Inc. today announced that it has launched Olanzapine Orally Disintegrating Tablets (ODT), 5 mg, 10 mg, 15 mg and 20 mg, the generic version of Eli Lilly and Company's Zyprexa Zydis Tablets.
› Verified 5 days ago
| Entity Name | Mercy Clinic Oklahoma Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386874550 PECOS PAC ID: 1153468921 Enrollment ID: O20091027000755 |
News Archive
Alcohol will cause around 135,000 cancer deaths over the next 20 years and will cost the NHS an estimated £2 billion in treatments, according to estimates from a new report by Sheffield University, commissioned by Cancer Research UK.
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
Johns Hopkins researchers have developed a novel way to monitor in real time the behavior of the TB bacterium in mouse lungs noninvasively pinpointing the exact location of Mycobacterium tuberculosis. The new monitoring system is expected to speed up what is currently a slow and cumbersome process to test the safety and efficacy of various TB drug regimens and vaccines in animals. Plans are already under way for developing a similar system to monitor TB disease in humans.
This post on the Center for Strategic & International Studies' (CSIS) SmartGlobalHealth.org blog provides resources, including video and publications, related to a December 6 half-day seminar, sponsored by the CSIS Global Health Policy Center, that "focused on the activities, practices, and strategies that characterize the global health outreach of Brazil, China, India, Russia and South Africa, or the BRICS."
Mylan Inc. today announced that it has launched Olanzapine Orally Disintegrating Tablets (ODT), 5 mg, 10 mg, 15 mg and 20 mg, the generic version of Eli Lilly and Company's Zyprexa Zydis Tablets.
› Verified 5 days ago
| Entity Name | Mercy Hospital Logan County, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306126818 PECOS PAC ID: 4587836200 Enrollment ID: O20121004000289 |
News Archive
Alcohol will cause around 135,000 cancer deaths over the next 20 years and will cost the NHS an estimated £2 billion in treatments, according to estimates from a new report by Sheffield University, commissioned by Cancer Research UK.
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
Johns Hopkins researchers have developed a novel way to monitor in real time the behavior of the TB bacterium in mouse lungs noninvasively pinpointing the exact location of Mycobacterium tuberculosis. The new monitoring system is expected to speed up what is currently a slow and cumbersome process to test the safety and efficacy of various TB drug regimens and vaccines in animals. Plans are already under way for developing a similar system to monitor TB disease in humans.
This post on the Center for Strategic & International Studies' (CSIS) SmartGlobalHealth.org blog provides resources, including video and publications, related to a December 6 half-day seminar, sponsored by the CSIS Global Health Policy Center, that "focused on the activities, practices, and strategies that characterize the global health outreach of Brazil, China, India, Russia and South Africa, or the BRICS."
Mylan Inc. today announced that it has launched Olanzapine Orally Disintegrating Tablets (ODT), 5 mg, 10 mg, 15 mg and 20 mg, the generic version of Eli Lilly and Company's Zyprexa Zydis Tablets.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Ford, DO 200 S Academy Rd, Guthrie, OK 73044-8727 Ph: (405) 260-4246 | Ashley Ford, DO 200 S Academy Rd, Guthrie, OK 73044-8727 Ph: (405) 260-4246 |
News Archive
Alcohol will cause around 135,000 cancer deaths over the next 20 years and will cost the NHS an estimated £2 billion in treatments, according to estimates from a new report by Sheffield University, commissioned by Cancer Research UK.
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
Johns Hopkins researchers have developed a novel way to monitor in real time the behavior of the TB bacterium in mouse lungs noninvasively pinpointing the exact location of Mycobacterium tuberculosis. The new monitoring system is expected to speed up what is currently a slow and cumbersome process to test the safety and efficacy of various TB drug regimens and vaccines in animals. Plans are already under way for developing a similar system to monitor TB disease in humans.
This post on the Center for Strategic & International Studies' (CSIS) SmartGlobalHealth.org blog provides resources, including video and publications, related to a December 6 half-day seminar, sponsored by the CSIS Global Health Policy Center, that "focused on the activities, practices, and strategies that characterize the global health outreach of Brazil, China, India, Russia and South Africa, or the BRICS."
Mylan Inc. today announced that it has launched Olanzapine Orally Disintegrating Tablets (ODT), 5 mg, 10 mg, 15 mg and 20 mg, the generic version of Eli Lilly and Company's Zyprexa Zydis Tablets.
› Verified 5 days ago
Dr. Arvind Bhakta, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 205 S Academy Rd, Guthrie, OK 73044 Phone: 405-282-9449 Fax: 405-282-9403 |